Mereo BioPharma (UK) Analysis
| 0A9G Stock | 3.72 0.10 2.76% |
Mereo BioPharma Group is overvalued with Real Value of 3.41 and Hype Value of 3.73. The main objective of Mereo BioPharma stock analysis is to determine its intrinsic value, which is an estimate of what Mereo BioPharma Group is worth, separate from its market price. There are two main types of Mereo BioPharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Mereo BioPharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Mereo BioPharma's stock to identify patterns and trends that may indicate its future price movements.
The Mereo BioPharma stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Mereo BioPharma is usually not traded on Spring Bank Holiday ( 2024 ), Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday. Mereo Stock trading window is adjusted to Europe/London timezone.
Mereo |
Mereo Stock Analysis Notes
About 68.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.28. Mereo BioPharma Group had not issued any dividends in recent years. For more info on Mereo BioPharma Group please contact Denise ScotsKnight at 44 33 3023 7300 or go to https://www.mereobiopharma.com.Mereo BioPharma Group Investment Alerts
| Mereo BioPharma generated a negative expected return over the last 90 days | |
| Mereo BioPharma has high historical volatility and very poor performance | |
| Mereo BioPharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1000 K. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 936 K. | |
| Mereo BioPharma generates negative cash flow from operations | |
| About 68.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: MREO Other Long-Term Liabilities 1.61 Mil - GuruFocus.com |
Management Efficiency
The company has return on total asset (ROA) of (0.3065) % which means that it has lost $0.3065 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7364) %, meaning that it generated substantial loss on money invested by shareholders. Mereo BioPharma's management efficiency ratios could be used to measure how well Mereo BioPharma manages its routine affairs as well as how well it operates its assets and liabilities. Net Tangible Assets is likely to gain to about 45.6 M in 2024, whereas Other Current Assets are likely to drop slightly above 406.3 K in 2024.Leadership effectiveness at Mereo BioPharma Group is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (38.07) | Beta 0.97 | Return On Assets (0.31) | Return On Equity (0.74) |
Technical Drivers
As of the 23rd of November, Mereo BioPharma secures the Mean Deviation of 2.78, risk adjusted performance of (0.06), and Standard Deviation of 3.73. Mereo BioPharma Group technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Mereo BioPharma Group treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if Mereo BioPharma Group is priced some-what accurately, providing market reflects its recent price of 3.72 per share.Mereo BioPharma Group Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mereo BioPharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mereo BioPharma Group. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Mereo BioPharma Predictive Daily Indicators
Mereo BioPharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mereo BioPharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 3.72 | |||
| Day Typical Price | 3.72 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.1 | |||
| Relative Strength Index | 51.69 |
Mereo BioPharma Forecast Models
Mereo BioPharma's time-series forecasting models are one of many Mereo BioPharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mereo BioPharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Mereo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Mereo BioPharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mereo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mereo BioPharma. By using and applying Mereo Stock analysis, traders can create a robust methodology for identifying Mereo entry and exit points for their positions.
Mereo BioPharma is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Mereo BioPharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.